Automated analysis and detection method and system for cell surface markers

Through microfluidic technology and high-dimensional flow cytometry combined with deep learning models, the cumbersome problems of cell isolation and labeling process are solved, efficient and accurate cell surface marker detection is achieved, and the efficiency and accuracy of analysis are improved.

CN118731352BActive Publication Date: 2024-12-06TIANJIN REAL AB BIOTECH
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411214759.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-12-06
Estimated Expiration
2044-09-02

AI Technical Summary

Technical Problem

In the prior art, the cell isolation and labeling process is complicated and error-prone, resulting in low efficiency in cell surface marker detection.

Method used

Microfluidic technology is used to isolate the target cell population, combine high-dimensional flow cytometry and metal isotopes or fluorescently labeled antibodies for labeling, use high-connotation screening technology and deep learning models for real-time analysis, combining single-cell sequencing and high-throughput cells Phenotyping analysis technology to realize automated analysis and detection.

Benefits of technology

It improves the accuracy and efficiency of cell surface marker detection, realizes simultaneous detection of multiple markers, reduces sample loss and contamination, and enhances the reliability of analysis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118731352B_ABST
    Figure CN118731352B_ABST
Patent Text Reader

Abstract

The present application provides an automated analysis and detection method and system for cell surface markers, which relates to the field of biological detection technology, including: separating multiple target cell populations; simultaneously marking multiple markers; automatically collecting cell signals, performing real-time analysis, and identifying cell surface marker expression patterns; performing joint analysis of gene expression and surface proteins on M random cells of any one of the multiple target cell populations; determining the cell surface marker expression level and cell subpopulation distribution, and combining with high-throughput cell phenotyping technology for automated analysis and detection. This application can solve the technical problem of low efficiency of cell surface marker detection in the prior art due to the cumbersome and error-prone cell separation and labeling process. Through high-dimensional flow cytometry, combined with automated analysis and detection, it is possible to achieve simultaneous detection of multiple cell markers, thereby improving the accuracy and efficiency of cell surface marker detection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biological detection technology, and in particular to an automated analysis and detection method and system for cell surface markers. Background Art

[0002] Cell surface markers are important components of cells and play a key role in cell recognition, signal transduction and function. In the field of bioassay technology, accurate analysis and detection of cell surface markers are crucial for understanding cell functions, disease mechanisms and developing new treatments. However, existing methods for analyzing and detecting cell surface markers have some technical challenges and limitations. Sample pretreatment processes the original biological sample into a form suitable for subsequent analysis, including cell separation, washing, fixation or other necessary processing steps. Existing sample pretreatment methods are cumbersome and error-prone, resulting in sample loss or contamination, which affects the accuracy and reliability of subsequent analysis. In addition, existing cell separation techniques may not be precise enough, resulting in the loss of target cell populations or contamination of non-target cell populations in the sample. This limits the accuracy and reliability of subsequent analysis.

[0003] In summary, the prior art has a technical problem of low efficiency in detecting cell surface markers due to the cumbersome and error-prone cell separation and labeling processes. Summary of the invention

[0004] The purpose of the present application is to provide an automated analysis and detection method and system for cell surface markers, in order to solve the technical problem in the prior art of low efficiency of cell surface marker detection due to cumbersome and error-prone cell separation and labeling processes.

[0005] In view of the above problems, the present application provides an automated analysis and detection method and system for cell surface markers.

[0006] In a first aspect, the present application provides an automated analysis and detection method for cell surface markers, which is implemented by an automated analysis and detection system for cell surface markers, wherein the automated analysis and detection method for cell surface markers comprises: pre-treating a target biological sample, separating multiple target cell populations using microfluidics technology; using high-dimensional flow cytometry, combined with metal isotope-labeled antibodies and / or fluorescently labeled antibodies, to simultaneously label multiple markers on the cell surfaces of the multiple target cell populations; based on the multiple markers on the cell surfaces of the multiple target cell populations , using high-content screening technology, automatically collect labeled cell signals, and use deep learning models to perform real-time analysis on the collected cell signals to identify cell surface marker expression patterns; based on the cell surface marker expression patterns, combined with single-cell sequencing technology, perform joint analysis of gene expression and surface proteins on M random cells of any target cell population among the multiple target cell populations to obtain single-cell level phenotypic information; based on the cell surface marker expression patterns and single-cell level phenotypic information, determine the cell surface marker expression levels and cell subpopulation distribution, and combine with high-throughput cell phenotypic analysis technology to perform automated analysis and detection.

[0007] In a second aspect, the present application further provides an automated analysis and detection system for cell surface markers, which is used to perform the automated analysis and detection method for cell surface markers as described in the first aspect, wherein the automated analysis and detection system for cell surface markers comprises: a sample preprocessing module, which is used to preprocess the target biological sample and separate multiple target cell populations using microfluidics technology; a marker labeling module, which is used to use high-dimensional flow cytometry, combined with metal isotope-labeled antibodies and / or fluorescently labeled antibodies, to simultaneously label multiple markers on the cell surfaces of the multiple target cell populations; a real-time analysis module, which is used to simultaneously label multiple markers on the cell surfaces of the multiple target cell populations based on the multiple markers on the cell surfaces of the multiple target cell populations. The invention relates to a single-cell sequencing module, which uses high-content screening technology to automatically collect labeled cell signals, and uses a deep learning model to perform real-time analysis on the collected cell signals to identify the expression pattern of cell surface markers; a single-cell sequencing module, which is used to perform a joint analysis of gene expression and surface proteins on M random cells of any target cell population among the multiple target cell populations based on the cell surface marker expression pattern and combined with single-cell sequencing technology to obtain single-cell level phenotypic information; an automated analysis module, which is used to determine the cell surface marker expression level and cell subpopulation distribution based on the cell surface marker expression pattern and single-cell level phenotypic information, and combines it with high-throughput cell phenotypic analysis technology to perform automated analysis and detection.

[0008] One or more technical solutions provided in this application have at least the following technical effects or advantages:

[0009] By pre-treating the target biological sample, multiple target cell groups are separated by microfluidic technology; high-dimensional flow cytometry is used, combined with metal isotope-labeled antibodies and / or fluorescent-labeled antibodies, to simultaneously label multiple markers on the cell surface of the multiple target cell groups; based on the multiple markers on the cell surface of the multiple target cell groups, high-content screening technology is used to automatically collect the labeled cell signals, and the collected cell signals are analyzed in real time through a deep learning model to identify the expression pattern of cell surface markers; based on the cell surface marker expression pattern, combined with single-cell sequencing technology, M random cells of any target cell group in the multiple target cell groups are subjected to joint analysis of gene expression and surface proteins to obtain single-cell level phenotypic information; based on the cell surface marker expression pattern and single-cell level phenotypic information, the cell surface marker expression level and cell subpopulation distribution are determined, and combined with high-throughput cell phenotypic analysis technology, automated analysis and detection are performed. In other words, through high-dimensional flow cytometry, combined with automated analysis and detection, the simultaneous detection of multiple cell markers is achieved, and the accuracy and efficiency of cell surface marker detection are improved.

[0010] The above description is only an overview of the technical solution of the present application. In order to more clearly understand the technical means of the present application, it can be implemented according to the contents of the specification, and in order to make the above and other purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are specifically cited below. It should be understood that the content described in this section is not intended to identify the key or important features of the embodiments of the present application, nor is it intended to limit the scope of the present application. Other features of the present application will become easy to understand through the following description. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] In order to more clearly illustrate the technical solutions in the present application or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only exemplary, and for ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying any creative work.

[0012] Figure 1 This is a schematic diagram of the process of the automated analysis and detection method for cell surface markers in this application;

[0013] Figure 2 This is a schematic diagram of the structure of the automated analysis and detection system for cell surface markers used in this application.

[0014] Explanation of the reference numerals: sample preprocessing module 11 , marker labeling module 12 , real-time analysis module 13 , single-cell sequencing module 14 , automated analysis module 15 . DETAILED DESCRIPTION

[0015] This application solves the technical problem of low efficiency of cell surface marker detection in the prior art due to the cumbersome and error-prone cell separation and labeling process by providing an automated analysis and detection method and system for cell surface markers. Through high-dimensional flow cytometry combined with automated analysis and detection, simultaneous detection of multiple cell markers is achieved, improving the accuracy and efficiency of cell surface marker detection.

[0016] Below, the technical solutions in the present application will be clearly and completely described with reference to the accompanying drawings. Obviously, the described embodiments are only part of the embodiments of the present application, rather than all of the embodiments of the present application. It should be understood that the present application is not limited to the example embodiments described herein. Based on the embodiments of the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application. It should also be noted that, for the convenience of description, only the parts related to the present application are shown in the accompanying drawings, rather than all of them.

[0017] For example, please refer to the attached Figure 1 The present application provides an automated analysis and detection method for cell surface markers, wherein the automated analysis and detection method for cell surface markers specifically comprises the following steps:

[0018] Step 1: Pre-treat the target biological sample and separate multiple target cell populations using microfluidics technology.

[0019] Specifically, samples are collected from tissues, blood or other biological fluids according to research needs, and the samples are washed and centrifuged to remove impurities in the samples, such as unattached cells, cell fragments, culture medium residues, etc., to ensure the quality of subsequent analysis. Microfluidics is a technology that manipulates fluids at a microscopic scale and is often used for cell separation and analysis. By designing microfluidic chips, precise manipulation and separation of cell populations can be achieved. Different cell populations are separated according to the physical or chemical properties of cells (such as size, shape, density, surface markers, etc.), thereby achieving specific separation of target cell populations. The separated target cell populations are collected in specific collection tubes or specific areas of microfluidic chips. Impurities in the sample are removed through pretreatment, and different cell populations are separated according to the physical or chemical properties of cells using microfluidics to achieve specific separation of target cell populations.

[0020] Step 2: High-dimensional flow cytometry is used in combination with metal isotope-labeled antibodies and / or fluorescently labeled antibodies to simultaneously label multiple markers on the cell surfaces of the multiple target cell populations.

[0021] Specifically, high-dimensional flow cytometry (such as CyTOF or advanced flow cytometer) is used to collect cell data and detect multiple parameters at the same time, that is, multiple different cell surface markers. High-dimensional flow cytometry is an advanced cell analysis technology that can detect multiple cell surface markers at the single cell level simultaneously. It uses multiple lasers and detectors with different wavelengths to analyze multiple parameters simultaneously, thereby achieving detailed characterization of cells. CyTOF uses mass spectrometry to detect metal isotope-labeled antibodies, which are not limited by spectral overlap and can simultaneously label and detect more than 30 parameters. Traditional flow cytometry uses fluorescently labeled antibodies, but due to the problem of fluorescence spectral overlap, the number of parameters that can be detected simultaneously is limited. Metal isotope-labeled antibodies are commonly used in mass spectrometry flow cytometry (CyTOF) using metal isotopes (such as cadmium, indium, iron, etc.) as labels. Fluorescently labeled antibodies are labeled with different fluorescent dyes and used in traditional flow cytometry. According to the research goals, antibodies targeting specific cell surface markers are selected, including monoclonal or polyclonal, and targeting different cell types and markers. Metal isotopes or fluorescent dyes are combined with antibodies to specifically bind to specific antigens on the cell surface, thereby achieving the labeling of cell surface markers. Through high-dimensional flow cytometry, multiple cell surface markers can be detected simultaneously, and metal isotope-labeled antibodies and / or fluorescent-labeled antibodies can be used to specifically label multiple markers on the cell surface, thereby improving the accuracy and throughput of the analysis.

[0022] Step three: Based on the multiple markers on the cell surface of the multiple target cell populations, high-content screening technology is used to automatically collect labeled cell signals, and the collected cell signals are analyzed in real time through a deep learning model to identify the expression pattern of cell surface markers.

[0023] Specifically, the images of labeled cells are automatically acquired using high-content screening technology, which includes cell morphology, intracellular and cell surface marker information, such as fluorescence signals, mass spectrometry signals, etc. High-content screening technology (HCS) is a high-throughput cell imaging and analysis technology that automatically acquires images and data of a large number of cells to achieve detailed analysis of cell populations. The HCS system can simultaneously detect multiple parameters, such as cell number, size, shape, texture, and fluorescence intensity and distribution of cell surface markers, thereby providing high-resolution cell feature information. The acquired cell images are preprocessed by automated software, including background subtraction, contrast enhancement, image segmentation, etc., to extract the characteristics of cells and cell surface markers. Deep learning models are trained using annotated data sets, such as convolutional neural networks (CNNs), recurrent neural networks (RNNs), or other models suitable for image analysis. The trained models are applied to real-time acquired cell signals to identify the expression patterns of cell surface markers, identify complex patterns and features in images, classify cells, identify different cell subpopulations, or discover new cell phenotypes through cluster analysis. Deep learning models can identify the expression patterns of cell surface markers from large amounts of data, thereby revealing the state and function of cells. Through high-content screening technology, large amounts of cell images and data are automatically collected to achieve high-throughput cell analysis. Using deep learning models, collected cell signals are analyzed in real time to quickly identify the expression patterns of cell surface markers.

[0024] Step 4: Based on the cell surface marker expression pattern and combined with single-cell sequencing technology, M random cells in the multiple target cell populations are subjected to a joint analysis of gene expression and surface proteins to obtain phenotypic information at the single-cell level.

[0025] Specifically, cell surface markers are labeled by high-dimensional flow cytometry. High-content screening technology is used to identify the expression patterns of cell surface markers and understand the characteristics and functions of different cell subpopulations. Single-cell sequencing technologies, such as single-cell RNA sequencing (scRNA-seq) and single-cell proteomics, simultaneously analyze gene expression and protein composition within a single cell. M cells are randomly selected from multiple target cell populations for single-cell level gene expression and surface protein analysis, providing unique gene expression and protein composition information for each cell. Single-cell sequencing technology is used to obtain the gene expression profile and protein composition of each cell, and the single-cell gene expression data is combined with the cell surface protein marker data to analyze the relationship between cell phenotype and gene expression pattern. Using single-cell sequencing technology, random cells in multiple target cell populations are jointly analyzed for gene expression and surface proteins to obtain phenotypic information at the single-cell level and gain a deeper understanding of the heterogeneity within the cell.

[0026] Step 5: Based on the cell surface marker expression pattern and single-cell level phenotypic information, the cell surface marker expression level and cell subpopulation distribution are determined, and combined with high-throughput cell phenotypic analysis technology, automated analysis and detection are performed.

[0027] Specifically, based on the expression pattern of cell surface markers, combined with the gene expression and protein composition information at the single-cell level, the unique characteristics of each cell are understood, and the expression level of cell surface markers and the distribution of different cell subpopulations in the sample are determined. High-throughput cell phenotyping technology, such as high-content screening system, is used to simultaneously detect and analyze the phenotypic characteristics of a large number of cells, such as cell morphology, expression and localization of intracellular proteins, etc. The cell surface marker expression pattern, single-cell level phenotypic information and high-throughput cell phenotyping technology are combined to achieve automated, high-throughput and precise analysis and detection of a large number of cell samples. High-throughput cell phenotyping technology is combined with automated analysis and detection to achieve rapid and accurate analysis of a large number of cell samples. Single-cell sequencing technology and high-throughput cell phenotyping technology are used in combination with automated analysis and detection to achieve a deep understanding of cell heterogeneity and phenotype.

[0028] Furthermore, step one of this application includes:

[0029] Tumor tissue is selected as the target biological sample to separate tumor tissue cell populations; at the same time, a microfluidic chip is used, wherein the microfluidic chip integrates microcolumn array technology and combines cell physical properties to perform cell separation, wherein the cell physical properties include cell size and electrophoretic mobility.

[0030] Specifically, tumor tissue, including tumor cells, immune cells, vascular endothelial cells, etc., is obtained from the patient's body through surgical resection, biopsy or other methods. Tumor tissue is selected as a sample to study the biological characteristics and pathological mechanisms of the tumor and understand the function of immune cells in the tumor microenvironment. Microfluidic chip is a device that manipulates fluids at a microscopic scale, usually composed of microchannels, micropumps, microvalves, etc. Microcolumn array technology is a technology integrated on a microfluidic chip. By setting a microcolumn array in a microchannel, precise manipulation and separation of cells can be achieved. Microcolumn arrays are usually designed with different sizes and spacings to separate cells according to their size. Smaller cells can pass through the microcolumn gaps, while larger cells are retained. Cell separation is performed based on the physical properties of cells, such as cell size and electrophoretic mobility. Cell size refers to the volume or diameter of a cell in three-dimensional space, while electrophoretic mobility refers to the speed at which a cell moves under the action of an electric field. By adjusting the parameters of the microcolumn array and the electric field conditions, cells of different sizes and electrophoretic mobilities can be separated. When the cell suspension flows through the microcolumn array, it is screened according to the size of the cells. For example, cancer stem cells are usually smaller than other tumor cells and can be separated by adjusting the size of the microcolumn gap. If the microfluidic chip is integrated with an electrophoresis module, an electric field is applied during the flow process to separate the cells according to their electrophoretic mobility (charge and size), further subdividing the cell populations, especially when the cells are of similar size. The separated cell populations are collected through the outlet of the microfluidic chip and directly used for subsequent analysis, such as cell counting, gene expression analysis, protein expression analysis, etc. Automated analysis and detection accelerates the research process of the tumor immune microenvironment and helps develop new immunotherapy methods.

[0031] Furthermore, the present application also includes the following steps:

[0032] A patient's blood sample is selected as the target biological sample to separate the white blood cell population; at the same time, the target biological sample is treated with an EDTA anticoagulant, and density gradient centrifugation technology is used in combination with white blood cell heterogeneity antibodies for cell separation, wherein the white blood cell heterogeneity antibodies include CD34-specific antibodies, CD38-specific antibodies, and HLA-DR-specific antibodies.

[0033] Specifically, a blood sample is collected from the patient, usually by venipuncture. Leukocytes are an important component of blood and play a key role in immune response and disease development. Blood samples are selected as target biological samples to study the patient's immune status and disease progression. Microfluidics technology is used to separate different leukocyte populations based on the physical or chemical properties of leukocytes (such as size, density, charge, etc.), to achieve precise manipulation and separation of specific leukocyte populations, and to provide a basis for subsequent cell surface marker analysis. Blood samples are treated with EDTA (ethylenediaminetetraacetic acid) as an anticoagulant to prevent blood coagulation. Typically, 1.5-2.0 ml of EDTA solution is added to every 10 ml of blood. When processing blood samples, EDTA is added to keep the blood in a liquid state, prevent blood cells from aggregating and coagulating, and thus maintain the original state of the sample.

[0034] Density gradient centrifugation is a commonly used cell separation technique. By adjusting the centrifugal speed and gradient medium, different cell populations can be separated according to the difference in cell density, and cell populations with large density differences, such as red blood cells, white blood cells and platelets in the blood, can be effectively separated. Ficoll separation solution is placed in a centrifuge tube to form a density gradient. The anticoagulated blood sample is gently superimposed on the Ficoll separation solution. Centrifuge at an appropriate speed and temperature, usually 400-1200g at room temperature for 20-30 minutes. After centrifugation, the blood sample will be divided into several different layers, with the white blood cell layer located between the Ficoll layer and the plasma layer. Specific white blood cell heterogeneity antibodies, such as CD34-specific antibodies, CD38-specific antibodies, and HLA-DR-specific antibodies, are used to identify and separate different white blood cell subsets. The diagnostic accuracy and efficiency of blood diseases are improved through automated analysis and detection.

[0035] Further, step three of this application includes:

[0036] The virus-infected cell sample is used as the target biological sample to separate the infected cell population; at the same time, the virus culture technology is used to track the dynamic changes in the expression pattern of cell surface markers during the virus infection process at different time points to determine the virus invasion mechanism.

[0037] Specifically, virus-infected cells are an important model for studying the mechanism of viral infection. By selecting virus-infected cells as samples, we can observe and study the effects of viruses on cells and understand the infection mechanism of viruses. Select a cell line suitable for viral growth and culture the cells under appropriate culture conditions. The virus is inoculated into the cells, usually by adsorption, centrifugation or the use of transfection reagents, and the virus is allowed to replicate in the cells under appropriate temperature and conditions. After viral infection, different time points (such as a few hours, a day, a few days after infection) are set to sample. If the virus or viral protein has a unique marker, use specific antibodies or dyes to mark the infected cells and separate them by flow cytometry or microfluidics. Different cell populations are separated according to the physical or chemical properties of the cells (such as size, density, charge, etc.), thereby achieving precise manipulation and separation of specific cell populations. Viral infection may change the expression of cell surface markers, and these changes are used to separate infected cell populations. Cell surface markers are labeled using metal isotope-labeled antibodies and / or fluorescently labeled antibodies, and cells at different time periods are analyzed by high-dimensional flow cytometry. HCS technology is used to obtain cell images, and changes in cell surface markers are analyzed through automated software. By comparing data at different time points and monitoring the dynamic changes in the expression of cell surface markers, it is revealed how the virus enters the cell, how it replicates in the cell, and how it affects the physiological functions of the cell, thereby determining the virus's invasion mechanism. Appropriate samples (virus-infected cells) are selected, and the dynamic changes in the expression pattern of cell surface markers are tracked using virus culture technology and high-content screening technology to determine the virus's invasion mechanism. Through automated analysis and detection, the progress of virology research has been accelerated and it is helpful to develop antiviral strategies.

[0038] Furthermore, the present application also includes the following steps:

[0039] PCR technology is used to quantitatively analyze the expression levels of specific viral genes in the infected cell population to monitor the progress and efficiency of viral infection; immunofluorescence staining technology is used in combination with antibodies to specific viral proteins to visualize the expression and distribution of viral proteins in the infected cell population, and cell proliferation experiments and cell apoptosis detection technology are performed to evaluate the effects of viral infection on cell growth and death and determine the pathogenicity of the virus; transcriptomics and proteomics technologies are combined to analyze the effects of viral infection on host cell gene expression and protein synthesis and determine the molecular mechanism of interaction between viruses and host cells; bioinformatics tools are used to construct a cell response network model corresponding to viral infection; based on the cell response network model corresponding to viral infection and according to the viral invasion mechanism, diagnostic markers and potential therapeutic targets for specific viruses are developed.

[0040] Specifically, total RNA is extracted from the infected cell population, and reverse transcriptase is used to transcribe RNA into cDNA. The expression level of specific viral genes is quantitatively analyzed by real-time quantitative PCR (qPCR) technology. Polymerase chain reaction (PCR) is a molecular biology technique used to amplify specific DNA fragments. Millions to billions of copies of specific DNA sequences are generated in a very short time through PCR. The expression level of specific viral genes is quantitatively analyzed to monitor the replication and spread of the virus in cells and understand the infection process of the virus. By comparing the expression levels of viral genes at different time points or under different conditions, the infection efficiency of the virus, that is, the replication speed and infection range of the virus in the cell, is evaluated. The viral infection process refers to the replication and spread process of the virus in the cell, and the viral infection efficiency refers to the replication speed and infection range of the virus in the cell. The infected cells are fixed on a slide and immunofluorescence staining is performed using antibodies against specific viral proteins. Immunofluorescence staining is a commonly used cell imaging technique that uses specific antibodies to bind to target proteins and then detects these target proteins with fluorescently labeled secondary antibodies. Antibodies are key reagents in immunofluorescence staining techniques, which specifically bind to viral proteins. By selecting specific antibodies, you can accurately detect and locate viral proteins. Observe the expression and distribution of viral proteins within infected cell populations.

[0041] The effects of viral infection on cell growth were evaluated using cell proliferation assays such as MTS colorimetry and BrdU incorporation assays. Cell apoptosis was detected by flow cytometry, ELISA, TUNEL staining, or fluorescent staining. Apoptosis is a process of programmed cell death, and detection of apoptosis is used to evaluate the effects of viral infection on cell survival. Transcriptomics and proteomics data were integrated and analyzed using bioinformatics tools. Transcriptomics is a technique for studying gene expression patterns. It analyzes the transcripts (RNA) of all genes in a cell to understand gene expression. It is usually achieved through RNA sequencing (RNA-seq) and provides information about gene expression levels, gene splicing, and transcriptional variation. Proteomics is a technique for studying protein composition and function. It analyzes the expression and modification of all proteins in a cell to understand the composition and function of proteins. It is usually achieved through mass spectrometry (such as LC-MS / MS) and provides information about protein expression levels, post-translational modifications, and protein-protein interactions. Transcriptomics and proteomics techniques were used to analyze gene expression and protein synthesis in host cells before and after viral infection. By comparing the gene expression and protein synthesis of host cells before and after viral infection, the molecular mechanism of the interaction between virus and host cells is revealed, including the expression of viral genes, the regulation of host cell genes and changes in protein synthesis pathways.

[0042] When constructing a cell response network model corresponding to viral infection, bioinformatics tools analyze a large amount of gene expression data, proteomics data, and other biological information. Bioinformatics is a discipline that uses computer science and information processing technology to process biological data. By analyzing gene expression and protein synthesis data before and after viral infection, a biological network model describing the cell's response to viral infection is constructed, including gene regulatory networks, signal transduction pathways, protein interaction networks, etc., to describe how cells respond to viral infection.

[0043] Analyze the cell response network model corresponding to viral infection to reveal how the virus invades host cells, including the key molecules and pathways of the interaction between the virus and the host cell. Based on the virus invasion mechanism, identify the molecules whose expression levels change significantly during the viral infection process as diagnostic markers for rapid and accurate detection of viral infection. Analyze the cell response network model to find the key molecules and pathways in the viral replication and infection process as potential therapeutic targets for the development of antiviral drugs. Through PCR technology, quantitatively analyze the expression level of viral genes to monitor the progress and efficiency of viral infection. Through immunofluorescence staining technology, visualize and analyze the expression and distribution of viral proteins to evaluate the effect of viruses on cell growth and death. Through transcriptomics and proteomics technology, analyze the effect of viral infection on gene expression and protein synthesis. Based on the cell response network model, develop diagnostic markers and potential therapeutic targets for specific viruses. Using a variety of technical means, comprehensively analyze the viral infection process from the molecular level to the cellular level, reveal the interaction mechanism between viruses and host cells, and provide a scientific basis for virus research and clinical application.

[0044] Furthermore, the present application also includes the following steps:

[0045] Use drug screening technology to screen known antiviral drugs and evaluate the therapeutic effects of known antiviral drugs on virus-infected cells; develop personalized medical strategies to build a customized treatment constraint space based on the patient's cell surface marker expression pattern and gene expression characteristics; use machine learning technology to continuously optimize and update the customized treatment constraint space.

[0046] Specifically, known antiviral drugs are collected and a drug library is established. Host cells are cultured in vitro and infected with specific virus strains. Different concentrations of antiviral drugs are added to infected cells, and control and experimental groups are set up. Through drug screening technology, known drugs that can be used to treat viral infections are screened to evaluate their efficacy on specific virus-infected cells, including testing multiple drug concentrations and durations of action to determine the best treatment plan. Drug screening is a high-throughput experimental method used to evaluate the effects of multiple drugs on specific cells or biological processes. In antiviral drug screening, the effects of drugs on viral replication, viral protein expression, and the viability of virus-infected cells are evaluated. Cell proliferation experiments, viral replication experiments, immunofluorescence staining and other methods are used to evaluate the therapeutic effects of known antiviral drugs on virus-infected cells, including the effects of drugs on viral replication, cell proliferation and apoptosis.

[0047] Collect cell samples from patients and analyze their cell surface marker expression patterns and gene expression characteristics. Analyze the expression patterns of patient cell surface markers through methods such as high-dimensional flow cytometry to understand the patient's immune status and pathological characteristics. Analyze the expression characteristics of patients' genes through transcriptomics technology to understand the patient's gene expression pattern and possible disease risk. Based on the cell surface marker expression pattern and gene expression characteristics, build a customized treatment constraint space, including treatment plans and treatment parameters suitable for patients. Personalized medicine is a medical approach based on individual patient characteristics, aiming to provide each patient with a treatment plan that best suits their specific situation.

[0048] Use machine learning technology to optimize the customized treatment constraint space, including adjusting treatment plans and parameters based on the patient's treatment response and treatment outcome data to improve treatment efficacy and adaptability. Use supervised learning, unsupervised learning, or reinforcement learning to train machine learning models. As new data accumulates and treatment experience increases, machine learning models continue to learn and adapt, thereby updating the treatment constraint space to more accurately reflect the patient's specific needs and treatment effects. Machine learning is an artificial intelligence technology that uses algorithms and data to enable computer systems to learn from experience and make predictions or decisions. In the medical field, machine learning is used to analyze large amounts of patient data to discover the relationship between treatment efficacy and patient characteristics. Using drug screening technology, personalized medical strategies, customized treatment constraint spaces, and machine learning technology, more accurate and personalized medical strategies can be achieved to provide patients with more effective treatment plans.

[0049] Further, step five of this application includes:

[0050] Quantification of cell surface marker expression levels ,in, is the fluorescence or luminescence intensity of the surface marker of the ith cell, is the background noise intensity of the ith cell, M is the total number of analyzed cells in any one of the multiple target cell populations; quantify the distribution of cell subpopulations in, Used to characterize the proportion of the jth cell subset, where N is the total number of cell subsets.

[0051] Specifically, Used to quantify the expression levels of cell surface markers, Indicates the expression level of cell surface markers, is the fluorescence or luminescence intensity of the surface marker of the ith cell, is the background noise intensity of the ith cell, and M represents the total number of analyzed cells in any target cell population among multiple target cell populations. The sum of the difference between the fluorescence or luminescence intensity of all cells and the background noise intensity is then divided by the total number of cells M to obtain the average expression level, which is used to compare the expression levels of cell surface markers in different cell populations or at different time points.

[0052] Represents the entropy value of cell subpopulation distribution, which is used to quantify the complexity of cell subpopulation distribution. represents the distribution entropy of cell subpopulations, Used to characterize the proportion of the jth cell subset, where N is the total number of cell subsets. The complexity of the cell subset distribution is quantified by calculating the proportion of each cell subset multiplied by its negative natural logarithm and then summing them. The higher the distribution entropy, the more uniform the cell subset distribution, that is, the more diverse the composition of the cell subset. These two formulas are used in the fields of cell biology and bioinformatics to quantify the expression levels of cell surface markers and the distribution of cell subsets, which helps to gain a deeper understanding of the biological characteristics and functions of cells.

[0053] In summary, the automated analysis and detection method for cell surface markers provided in this application has the following technical effects:

[0054] By pre-treating the target biological sample, multiple target cell groups are separated by microfluidic technology; high-dimensional flow cytometry is used, combined with metal isotope-labeled antibodies and / or fluorescent-labeled antibodies, to simultaneously label multiple markers on the cell surface of the multiple target cell groups; based on the multiple markers on the cell surface of the multiple target cell groups, high-content screening technology is used to automatically collect the labeled cell signals, and the collected cell signals are analyzed in real time through a deep learning model to identify the expression pattern of cell surface markers; based on the cell surface marker expression pattern, combined with single-cell sequencing technology, M random cells of any target cell group in the multiple target cell groups are subjected to joint analysis of gene expression and surface proteins to obtain single-cell level phenotypic information; based on the cell surface marker expression pattern and single-cell level phenotypic information, the cell surface marker expression level and cell subpopulation distribution are determined, and combined with high-throughput cell phenotypic analysis technology, automated analysis and detection are performed. In other words, through high-dimensional flow cytometry, combined with automated analysis and detection, the simultaneous detection of multiple cell markers is achieved, and the accuracy and efficiency of cell surface marker detection are improved.

[0055] Example 2: Based on the same inventive concept as the automated analysis and detection method for cell surface markers in the previous example, the present application also provides an automated analysis and detection system for cell surface markers, see the attached Figure 2 , the automated analysis and detection system for cell surface markers comprises:

[0056] The sample preprocessing module 11 is used to preprocess the target biological sample and separate multiple target cell groups using microfluidics technology.

[0057] The marker labeling module 12 is used to simultaneously label multiple markers on the cell surfaces of the multiple target cell populations by using high-dimensional flow cytometry in combination with metal isotope-labeled antibodies and / or fluorescently labeled antibodies.

[0058] The real-time analysis module 13 is used to automatically collect labeled cell signals based on the multiple markers on the cell surface of the multiple target cell groups using high-content screening technology, and to perform real-time analysis on the collected cell signals through a deep learning model to identify the expression pattern of cell surface markers.

[0059] The single-cell sequencing module 14 is used to perform a joint analysis of gene expression and surface proteins on M random cells of any one of the multiple target cell populations based on the cell surface marker expression pattern in combination with single-cell sequencing technology to obtain phenotypic information at the single-cell level.

[0060] The automated analysis module 15 is used to determine the cell surface marker expression level and cell subpopulation distribution based on the cell surface marker expression pattern and single cell level phenotypic information, and to perform automated analysis and detection in combination with high-throughput cell phenotypic analysis technology.

[0061] Furthermore, the sample preprocessing module 11 in the automated analysis and detection system for cell surface markers is also used for:

[0062] Tumor tissue is selected as the target biological sample to separate tumor tissue cell populations; at the same time, a microfluidic chip is used, wherein the microfluidic chip integrates microcolumn array technology and combines cell physical properties to perform cell separation, wherein the cell physical properties include cell size and electrophoretic mobility.

[0063] Furthermore, the sample preprocessing module 11 in the automated analysis and detection system for cell surface markers is also used for:

[0064] A patient's blood sample is selected as the target biological sample to separate the white blood cell population; at the same time, the target biological sample is treated with an EDTA anticoagulant, and density gradient centrifugation technology is used in combination with white blood cell heterogeneity antibodies for cell separation, wherein the white blood cell heterogeneity antibodies include CD34-specific antibodies, CD38-specific antibodies, and HLA-DR-specific antibodies.

[0065] Furthermore, the real-time analysis module 13 in the automated analysis and detection system for cell surface markers is also used for:

[0066] The virus-infected cell sample is used as the target biological sample to separate the infected cell population; at the same time, the virus culture technology is used to track the dynamic changes in the expression pattern of cell surface markers during the virus infection process at different time points to determine the virus invasion mechanism.

[0067] Furthermore, the real-time analysis module 13 in the automated analysis and detection system for cell surface markers is also used for:

[0068] PCR technology is used to quantitatively analyze the expression levels of specific viral genes in the infected cell population to monitor the progress and efficiency of viral infection; immunofluorescence staining technology is used in combination with antibodies to specific viral proteins to visualize the expression and distribution of viral proteins in the infected cell population, and cell proliferation experiments and cell apoptosis detection technology are performed to evaluate the effects of viral infection on cell growth and death and determine the pathogenicity of the virus; transcriptomics and proteomics technologies are combined to analyze the effects of viral infection on host cell gene expression and protein synthesis and determine the molecular mechanism of interaction between viruses and host cells; bioinformatics tools are used to construct a cell response network model corresponding to viral infection; based on the cell response network model corresponding to viral infection and according to the viral invasion mechanism, diagnostic markers and potential therapeutic targets for specific viruses are developed.

[0069] Furthermore, the real-time analysis module 13 in the automated analysis and detection system for cell surface markers is also used for:

[0070] Use drug screening technology to screen known antiviral drugs and evaluate the therapeutic effects of known antiviral drugs on virus-infected cells; develop personalized medical strategies to build a customized treatment constraint space based on the patient's cell surface marker expression pattern and gene expression characteristics; use machine learning technology to continuously optimize and update the customized treatment constraint space.

[0071] Furthermore, the automated analysis module 15 in the automated analysis and detection system for cell surface markers is also used for:

[0072] Quantification of cell surface marker expression levels ,in, is the fluorescence or luminescence intensity of the surface marker of the ith cell, is the background noise intensity of the ith cell, M is the total number of analyzed cells in any one of the multiple target cell populations; quantify the distribution of cell subpopulations ,in, Used to characterize the proportion of the jth cell subset, where N is the total number of cell subsets.

[0073] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. Figure 1The automated analysis and detection method for cell surface markers and the specific examples in Example 1 are also applicable to the automated analysis and detection system for cell surface markers in this embodiment. Through the detailed description of the automated analysis and detection method for cell surface markers, those skilled in the art can clearly know the automated analysis and detection system for cell surface markers in this embodiment, so for the sake of brevity of the specification, it is not described in detail here. For the system disclosed in the embodiment, since it corresponds to the method disclosed in the embodiment, the description is relatively simple, and the relevant parts can be referred to the method part description.

[0074] The above description of the disclosed embodiments enables those skilled in the art to implement or use the present application. Various modifications to these embodiments will be apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present application. Therefore, the present application will not be limited to the embodiments shown herein, but will conform to the widest scope consistent with the principles and novel features disclosed herein.

[0075] Obviously, those skilled in the art can make various changes and modifications to the present application without departing from the spirit and scope of the present application. Thus, if these modifications and variations of the present application belong to the scope of the present application and its equivalent technology, the present application is also intended to include these modifications and variations.

Claims

1. An automated analysis and detection method for cell surface markers, characterized in that: include: Pre-treat the target biological sample and separate multiple target cell populations using microfluidics technology; High-dimensional flow cytometry is used in combination with metal isotope-labeled antibodies and / or fluorescently labeled antibodies to simultaneously label multiple markers on the cell surfaces of the multiple target cell populations; Based on the multiple markers on the cell surfaces of the multiple target cell populations, high-content screening technology is used to automatically collect the labeled cell signals, and the collected cell signals are analyzed in real time through a deep learning model to identify the expression pattern of the cell surface markers; Based on the cell surface marker expression pattern, combined with single-cell sequencing technology, M random cells of any one of the multiple target cell populations are subjected to a joint analysis of gene expression and surface protein to obtain phenotypic information at the single-cell level; Based on the cell surface marker expression pattern and single cell level phenotypic information, the cell surface marker expression level and cell subpopulation distribution are determined, and combined with high-throughput cell phenotypic analysis technology, automated analysis and detection is performed; The method of performing real-time analysis on collected cell signals through a deep learning model to identify the expression pattern of cell surface markers also includes: Using a virus-infected cell sample as the target biological sample, and isolating an infected cell population; At the same time, using virus culture technology, the dynamic changes in the expression pattern of cell surface markers during virus infection were tracked at different time points to determine the mechanism of virus invasion; Wherein, the method further comprises: Using PCR technology, quantitatively analyzing the expression level of specific viral genes in the infected cell population to monitor the viral infection process and viral infection efficiency; Immunofluorescence staining technology is used in combination with antibodies against specific viral proteins to visualize the expression and distribution of viral proteins in the infected cell population, and cell proliferation experiments and cell apoptosis detection techniques are performed to evaluate the effects of viral infection on cell growth and death and determine the pathogenicity of the virus; Combine transcriptomics and proteomics techniques to analyze the effects of viral infection on host cell gene expression and protein synthesis, and determine the molecular mechanisms of interaction between viruses and host cells; Use bioinformatics tools to build a cellular response network model corresponding to viral infection; Based on the cell response network model corresponding to viral infection and the viral invasion mechanism, develop diagnostic markers and potential therapeutic targets for specific viruses; Wherein, the method further comprises: Use drug screening technology to screen known antiviral drugs and evaluate the therapeutic effects of known antiviral drugs on virus-infected cells; Develop personalized medical strategies and build customized treatment constraint spaces based on the patient's cell surface marker expression patterns and gene expression characteristics; The customized treatment constraint space is continuously optimized and updated using machine learning technology.

2. The automated analysis and detection method for cell surface markers according to claim 1, characterized in that: Pre-process the target biological samples and separate multiple target cell populations using microfluidics technology, including: Selecting tumor tissue as the target biological sample, and isolating a tumor tissue cell population; At the same time, a microfluidic chip is used, which integrates microcolumn array technology and combines cell physical properties to perform cell separation, wherein the cell physical properties include cell size and electrophoretic mobility.

3. The automated analysis and detection method for cell surface markers according to claim 2, characterized in that: Also includes: Selecting a patient's blood sample as the target biological sample, and separating a leukocyte population; At the same time, the target biological sample is treated with EDTA anticoagulant, and cell separation is performed using density gradient centrifugation technology combined with leukocyte heterogeneity antibodies. The leukocyte heterogeneity antibodies include CD34-specific antibodies, CD38-specific antibodies, and HLA-DR-specific antibodies.

4. The automated analysis and detection method for cell surface markers according to claim 3, characterized in that: Based on the cell surface marker expression pattern and single cell level phenotypic information, the cell surface marker expression level and cell subpopulation distribution are determined, and combined with high-throughput cell phenotypic analysis technology to perform automated analysis and detection, further comprising: Quantification of cell surface marker expression levels ,in, Indicates the expression level of cell surface markers, is the fluorescence or luminescence intensity of the surface marker of the ith cell, is the background noise intensity of the ith cell, M is the total number of analyzed cells of any one of the multiple target cell populations; Quantification of cell subpopulation distribution ,in, represents the distribution entropy of cell subpopulations, Used to characterize the proportion of the jth cell subset, where N is the total number of cell subsets.

Citation Information

Patent Citations

  • Unicell based immunocyte typing quantitative analysis method

    CN110412287A

  • Application of single cell sequencing as marker in preparation of diagnostic primary sicca syndrome

    CN113564246A

  • Microfluidic Devices and Methods for Use Thereof in Multicellular Assays of Secretion

    US20160252495A1